SEC Form 4
Abbott Laboratories (ABT) insider trading
In the 12 months to Oct 24, 2026, 7 ABT insiders reported open-market sales of $47.5M across 10 filings; 4 insiders bought $4.4M.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $47.5M
- 10 filings · 7 insiders
- Open-market purchases
- $4.4M
- 5 filings
Who traded ABT, and when
- Purchase
- Sale
ABT daily close from Oct 24, 2025 to Oct 23, 2026, between $82.56 and $130.59, last $103.70. 10 sale and 5 purchase filings by 10 insiders, marked at their filing dates. Robert B. Ford, CHAIRMAN AND CEO: sold $46.2M and bought $2.0M across 2 filings, first filed Jan 26, 2026, last Aug 27, 2026. Daniel J. Starks, Director: bought $2.0M across 2 filings, first filed Feb 6, 2026, last Apr 28, 2026. Louis H. Morrone, EXECUTIVE VICE PRESIDENT: sold $774.7K across 2 filings, first filed Mar 3, 2026, last Aug 13, 2026. Eric Shroff, Senior Vice President: sold $285.0K across 2 filings, first filed Nov 25, 2025, last Mar 3, 2026. Philip P. Boudreau, EVP AND CFO: bought $201.3K across 1 filing, first filed Apr 27, 2026, last Apr 27, 2026. John G. Stratton, Director: bought $173.6K across 1 filing, first filed Jun 18, 2026, last Jun 18, 2026. 4 others: sold $274.1K across 5 filings, first filed Mar 3, 2026, last Sep 3, 2026.
Largest mark · tap a row for others
Robert B. Ford · CHAIRMAN AND CEO
Sale $46,204,798
398,832 shares at $115.85 avg
Filed Aug 27, 2026 · traded Aug 25
Close on filing date $111.59
Robert B. Ford · CHAIRMAN AND CEO
CHAIRMAN AND CEO
$46.2M sold$2.0M boughtDaniel J. Starks · Director
Director
$2.0M boughtLouis H. Morrone · EXECUTIVE VICE PRESIDENT
EXECUTIVE VICE PRESIDENT
$774.7K soldEric Shroff · Senior Vice President
Senior Vice President
$285.0K soldPhilip P. Boudreau · EVP AND CFO
EVP AND CFO
$201.3K boughtJohn G. Stratton · Director
Director
$173.6K bought4 others
Combined, one mark per week
$274.1K soldHas Abbott Laboratories' CEO sold stock?
Yes. Robert B. Ford (CEO) sold 398,832 shares ($46.2M) in Aug 2026.
Open-market trades
15 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Robert B. Ford | CHAIRMAN AND CEO | $46.2M | $2.0M | 2 | — | |
| Daniel J. Starks | Director | — | $2.0M | 2 | — | |
| Louis H. Morrone | EXECUTIVE VICE PRESIDENT | $774.7K | — | 2 | — | |
| Eric Shroff | Senior Vice President | $285.0K | — | 2 | — | |
| Philip P. Boudreau | EVP AND CFO | — | $201.3K | 1 | — | |
| John G. Stratton | Director | — | $173.6K | 1 | — | |
| Daniel Gesua Sive Salvadori | EVP AND GROUP PRESIDENT | $102.3K | — | 1 | — | |
| Mary K. Moreland | EXECUTIVE VICE PRESIDENT | $70.9K | — | 1 | — | |
| John A. Mccoy JR. | VICE PRESIDENT AND CONTROLLER | $70.6K | — | 2 | — | |
| Elizabeth C. Cushman | EVP, GC AND SECRETARY | $30.4K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | John A. Mccoy JR. VICE PRESIDENT AND CONTROLLER | Sale | 27 | $109.54 | $3.0K | 24,549 | |
traded | Robert B. Ford CHAIRMAN AND CEO | Sale | 398,832 | $115.85 | $46.2M | 306,461 | |
traded | Louis H. Morrone EXECUTIVE VICE PRESIDENT | Sale | 5,850 | $109.83 | $642.5K | 70,724 | |
traded | John G. Stratton Director | Purchase | 2,000 | $86.82 | $173.6K | 23,319 | |
traded | Daniel J. Starks Director | Purchase | 10,000 | $92.65 | $926.5K | 6,751,103 | |
traded | Philip P. Boudreau EVP AND CFO | Purchase | 2,200 | $91.50 | $201.3K | 2,200 | |
traded | Daniel Gesua Sive Salvadori EVP AND GROUP PRESIDENT | Sale | 885 | $115.58 | $102.3K | 146,377 | |
traded | John A. Mccoy JR. VICE PRESIDENT AND CONTROLLER | Sale | 585 | $115.58 | $67.6K | 24,628 | |
traded | Mary K. Moreland EXECUTIVE VICE PRESIDENT | Sale | 613 | $115.58 | $70.9K | 104,291 | |
traded | Louis H. Morrone EXECUTIVE VICE PRESIDENT | Sale | 1,144 | $115.58 | $132.2K | 76,843 | |
traded | Eric Shroff Senior Vice President | Sale | 709 | $115.58 | $81.9K | 39,164 | |
traded | Elizabeth C. Cushman EVP, GC AND SECRETARY | Sale | 263 | $115.58 | $30.4K | 38,573 | |
traded | Daniel J. Starks Director | Purchase | 10,000 | $108.73 | $1.1M | 6,738,817 | |
traded | Robert B. Ford CHAIRMAN AND CEO | Purchase | 18,800 | $107.13 | $2.0M | 216,203 | |
traded | Eric Shroff Senior Vice President | Sale | 1,586 | $128.02 | $203.0K | 30,384 |
GET /stocks/filings/vX/form-4?tickers=ABT&filing_date.gte=2025-10-24&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"ABT"
],
"issuer_cik": "0000001800",
"owner_cik": "0001644207",
"accession_number": "0001644207-26-000012",
"form_type": "4",
"filing_date": "2026-09-03",
"period_of_report": "2026-09-01",
"issuer_name": "ABBOTT LABORATORIES",
"issuer_trading_symbol": "ABT",
"owner_name": "MCCOY JOHN A. JR.",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "VICE PRESIDENT AND CONTROLLER",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common shares without par value",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-02",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 27,
"transaction_price_per_share": 109.54,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 24549,
"transaction_value": 2957.5800000000004,
"direct_or_indirect": "D"
},
{
"tickers": [
"ABT"
],
"issuer_cik": "0000001800",
"owner_cik": "0001612571",
"accession_number": "0001612571-26-000011",
"form_type": "4",
"filing_date": "2026-08-27",
"period_of_report": "2026-08-25",
"issuer_name": "ABBOTT LABORATORIES",
"issuer_trading_symbol": "ABT",
"owner_name": "Ford Robert B",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "CHAIRMAN AND CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common shares without par value",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-25",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 218535,
"transaction_price_per_share": 115.57,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 486758,
"transaction_value": 25256089.95,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.09 to $116.08, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 44 records
- Option exercises2 records
- Tax withholding15 records
- Grants and awards23 records
- Gifts1 record
- Other3 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for ABT every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.